AUSTIN, Texas — Kinnser Software, the Austin-based national software leader in clinical and business solutions for post-acute care businesses, announced today that it has finalized an agreement to merge with Mediware, a well-established leader in healthcare software for almost 40 years. Kinnser’s software as a service (SaaS) solutions expand the Mediware portfolio to address home health and hospice, two rapidly growing healthcare sectors.

The merger is backed by TPG Capital, a leading private equity platform with two of the most experienced investment teams in software and healthcare. TPG finalized its acquisition of Mediware in February 2017.

“Kinnser’s merger with Mediware supports our mission to provide our customers with innovative solutions that support excellent care and profitable growth,” said Chris Hester, president and founder of Kinnser Software. “Not only will our combined company enable us to expand our offerings and serve even more customers; it will also fuel innovation allowing more patients to benefit from better, more attentive care as a direct result of the work we do. I am excited to continue to lead Kinnser as a part of Mediware. I express my sincere appreciation and thanks to Insight Venture Partners and Georgian Partners. Without their mentorship and support Kinnser would have been unable to develop the innovations that are now transforming healthcare at home and improving the lives of thousands of patients every day.”

Founded in 2003, Kinnser Software provides web-based solutions that deliver clinical and business results to more than 4,000 home health, hospice, therapy, and private duty home care agencies nationwide. Kinnser is one of the most rapidly growing companies in post-acute healthcare, and its solutions are among the most widely used. In 2016 alone, more than 30 million billable patient visits were performed using Kinnser solutions.

Kinnser has consistently remained a respected and innovative pioneer, empowering home health and hospice providers to provide high-quality, technology-connected healthcare at home.

“Kinnser is a company that cares deeply about the success of home health and hospice providers,” said Sharon Harder, president of Chicago-based healthcare consulting firm C3 Advisors, LLC. “From developing innovative web-based solutions that empower data-driven care, to providing free educational resources to the industry, Kinnser is consistently at the forefront.”

The merger brings no planned changes to Kinnser’s mission, its focus on customer success, its staff, or headquarters.

Mediware’s portfolio of solutions includes blood services, cellular therapy, medication management, physical rehabilitation, respiratory therapy, behavioral health, and home care. The addition of Kinnser’s enterprise solutions for home health and hospice represents a synergy that is exciting for both companies.

“Kinnser’s intuitive platform provides Mediware with additional depth, expertise, and capabilities to strengthen our platform in the home health and hospice space,” said Thomas Mann, CEO of Mediware.

“Kinnser and Mediware share the same strategic vision — that technology can transform the delivery of healthcare,” said Kinnser president and founder Chris Hester. “Together, we look forward to even greater advances that will serve the broad continuum of healthcare.”

# # #

About Kinnser Software
Kinnser Software, Inc. provides web-based solutions that deliver clinical and business results to the home health, hospice, and private duty industries. Founded in 2003 and headquartered in Austin, Texas, Kinnser Software serves more than 4,000 home health, hospice, therapy, and private duty home care providers nationwide. Kinnser helps thousands of clinicians and other staff in post-acute healthcare to manage scheduling, billing, electronic visit verification, day-to-day operations, and patient referrals. Learn more at

About Mediware
Since 1980, Mediware has provided software solutions to healthcare providers and has since expanded to serve many state and federal agencies. Mediware’s solutions are perfect for high-growth, complex patient care environments that remain underserved by existing vendors. The company employs more than 650 subject matter experts who deeply understand business and care processes in highly specialized acute, non-acute, and community-based care settings and have years of experience integrating systems. Mediware’s portfolio of solutions currently includes human and social services, blood, cellular therapy, home care, medication management, rehabilitation, and respiratory therapy. For more information about Mediware products and services, visit

About TPG
TPG is a leading global alternative asset firm founded in 1992 with approximately $72 billion of assets under management and offices in Austin, Beijing, Boston, Dallas, Fort Worth, Hong Kong, Houston, London, Luxembourg, Melbourne, Moscow, Mumbai, New York, San Francisco, Seoul, and Singapore. TPG’s investment platforms are across a wide range of asset classes, including private equity, growth venture, real estate, credit, and public equity. TPG aims to build dynamic products and options for its investors while also instituting discipline and operational excellence across its investment strategies and the performance of its portfolio. For more information, visit